SKI Market

Indian Indices

Nifty

25,461.00 55.70
(0.22%)

Sensex

83,432.89 193.42
( 0.23%)

Bank Nifty

57,031.90 239.95
( 0.42%)

Nifty IT

39,166.55 312.25
( 0.80%)

Global Indices

Nasdaq

44,849.54 344.11
(0.77%)

Dow Jones

6,300.35 51.93
(0.83%)

Hang Seng

39,792.23 6.33
(0.02%)

Nikkei 225

8,822.91 -0.29
(0.00%)

Forex

USD-INR

85.44 -0.20
(-0.23%)

EUR-INR

100.61 -0.32
(-0.32%)

GBP-INR

116.59 -0.52
(-0.45%)

JPY-INR

0.59 0.00
(-0.64%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

290.2218799

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

37.05

33569.5

EPS(TTM)

Face Value()

Div & Yield %

72.53

1.05

Back

ajanta pharma ltd

Ajanta Pharma consolidated net profit rises 10.84% in the September 2024 quarter

Oct 28,2024

Net profit of Ajanta Pharma rose 10.84% to Rs 216.48 crore in the quarter ended September 2024 as against Rs 195.30 crore during the previous quarter ended September 2023. Sales rose 15.38% to Rs 1186.64 crore in the quarter ended September 2024 as against Rs 1028.44 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	1186.64	1028.44	15
OPM %	26.22	28.26	-
PBDT	324.63	309.65	5
PBT	290.24	275.94	5
NP	216.48	195.30	11

25,461.00 55.70 (0.22%)

83,432.89 193.42 ( 0.23%)

57,031.90 239.95 ( 0.42%)

39,166.55 312.25 ( 0.80%)

44,849.54 344.11 (0.77%)

6,300.35 51.93 (0.83%)

39,792.23 6.33 (0.02%)

8,822.91 -0.29 (0.00%)

85.44 -0.20 (-0.23%)

100.61 -0.32 (-0.32%)

116.59 -0.52 (-0.45%)

0.59 0.00 (-0.64%)